The feeling of pride is something most of us are familiar with—but what exactly does it mean? What makes us proud of ourselves? In this article, we explore these questions.
Why do so many people remain undiagnosed, even though their symptoms may have been present for decades? Alpha-1 is a rare genetic condition that often goes unnoticed. Raising awareness and recognizing its signs are essential for early detection. In November, during Alpha-1 Awareness Month, a global effort takes place to draw attention to this disease, in which plasma proteins play a key role both in its development and treatment.
Why is it important for everyone to be aware of it? How can you help your community better understand and recognize the symptoms of Alpha-1 antitrypsin deficiency? This month provides an opportunity to deepen our understanding of the condition and support those affected—while also highlighting the importance of plasma donation.
Get to Know the Plasma Protein That Protects Your Lungs
Alpha-1 antitrypsin is a vital plasma protein. Its name comes from its function: it inhibits enzymes such as trypsin, chymotrypsin, and elastase, which break down proteins. These enzymes play an important role in digesting dietary proteins and defending the body against infectious agents.
However, their activity must be carefully regulated, as excessive enzyme activity can damage healthy tissues. This is where alpha-1 antitrypsin plays a crucial role.
In people with alpha-1 antitrypsin deficiency, the level of AAT is low, or the protein is structurally altered and unable to perform its function properly. This can lead to liver and lung problems. The condition is caused by a genetic mutation, resulting in insufficient production of functional alpha-1 antitrypsin. Without it, other enzymes can damage lung and liver tissues, potentially leading to emphysema, chronic lung disease, or liver cirrhosis.
Plasma proteins collected during plasma donation can be essential in treating affected patients. This makes plasma donation a key factor in managing alpha-1 antitrypsin deficiency. In Hungary, approximately 50 children are born each year with this genetic condition, and globally, more than 3 million people are affected.
Many individuals live with symptoms for years—or even decades—without knowing the cause of issues such as shortness of breath at a young age, chronic bronchitis, or emphysema.
It is crucial for the healthcare community and patient organizations to work together to raise awareness and improve the early diagnosis of alpha-1 antitrypsin deficiency.
Together for Hope: The Role of Haema Plasma in Supporting Alpha-1 Patients
Haema Plasma has been committed for decades to providing plasma proteins for therapeutic use. We support patients by collecting plasma donations that contribute to their treatment by replacing missing proteins. The plasma proteins collected during donation can be life-saving for those living with alpha-1 antitrypsin deficiency. Haema Plasma continuously works to provide the highest level of service for both donors and patients.
Stronger Together
November is a time when we can all take a step toward better understanding and supporting Alpha-1, while also emphasizing the importance of plasma donation. Here are a few ways you can get involved:
- Stay informed and spread awareness! Share information about Alpha-1 with your friends and family.
- Donate plasma! Plasma donation plays a vital role in the treatment of Alpha-1.
- Be part of the community! Participate in events and campaigns, and show your support.
The Power of Community
The stories of affected patients highlight not only the severity of the disease but also the importance of diagnosis. Many individuals are diagnosed only after prolonged recovery from pneumonia or after experiencing persistent and worsening respiratory symptoms.
Learning about these stories is not only inspiring but also underscores the importance of early detection and community support.
A Global Movement You Can Join
Alpha-1 Awareness Month offers an opportunity for all of us to support the Alpha-1 community, promote a better understanding of the condition, and emphasize the importance of plasma donation. Together, we can take a step toward greater awareness and improving the quality of life for those affected.
